Table 1 Demographic data of the enrolled subjects and characteristics of the PFCs.
Variables | Patients with symptomatic PFCs (n = 33) |
|---|---|
Age, mean ± SD (range), years | 53.93 ± 15.28 (20–87) |
Sex, female/male, n (%) | 13 (39.39)/20 (60.61) |
BMI, mean ± SD, kg/m2 (range) | 24.13 ± 4.99 (17.00–37.66) |
Comorbidities, n (%) | |
None | 3 (9.09) |
Cardiovascular disease | 6 (18.18) |
Cerebrovascular disease | 3 (9.09) |
Chronic liver disease | 5 (15.15) |
Chronic kidney disease | 2 (6.06) |
Hypertension/DM/Hyperlipidemia | 23 (69.69) |
Malignancy | 6 (18.18) |
Etiology of pancreatitis, n (%) | |
Gallstones | 9 (27.27) |
Alcohol | 8 (24.24) |
Hypertriglyceridemia | 4 (12.12) |
Malignancy* | 5 (15.15) |
Others# | 7 (21.21) |
Symptoms of the PFC, n (%) | |
Abdominal pain | 24 (72.73) |
Infection | 7 (21.21) |
GI tract obstruction | 2 (6.06) |
Types of PFC, n (%) | |
Pseudocyst | 14 (42.42) |
Walled-off necrosis | 19 (57.58) |
Proportion of necrotic area, mean ± SD (range), % | 63.50 ± 23.46 (30.00–90.00) |
Size of the PFC, mean ± SD (range), cm | 10.77 ± 5.48 (3.30–25.00) |
Characteristics of the PFC, n (%) | |
CT Balthazar grade (A/B/C/D/E) | 0 (0)/0 (0)/5 (15.15)/19 (57.58)/9 (27.27) |
Unilocular/Multilocular (communicating/non-communicating) | 25 (75.76)/8 (24.24) [4 (50.00)/4 (50.00)] |
Paracolic gutter extension | 7 (21.21) |
Follow-up period, mean ± SD (range), days | 421.97 ± 397.75 (65–2065) |
